S. M. Tarczewski

发表

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.

M. Korc, T. Gardner, Kerrington D. Smith, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

VEGF remains an interesting target in advanced pancreas cancer ( APCA ) : results of a multi-institutional phase II study of bevacizumab , gemcitabine , and infusional 5-fl uorouracil in patients with APCA

M. Korc, T. Gardner, S. Gordon, 2012 .